X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


Latest Post

July 10, 2019

Intended Use and Packaging Risks for Compounding Pharmacies (503Bs)

In 2015, the FDA shed light on a problematic practice within the healthcare industry involving improper, off-label use of syringes as closed container storage systems for compounded or repackaged drugs. The incidents cited revealed that interaction with rubber plungers in syringes that were not cleared for the purpose of closed container storage resulted in the loss of potency of several drugs when administration was delayed.<sup>1</sup>
Amy Kim

Amy Kim

Sr. Specialist, Scientific Communications, SA & TS

Previous Posts
Elastomers

June 25, 2019

Bromobutyl versus Chlorobutyl Rubber Formulations - General Aspects

Heike Kofler

Dr. Heike Kofler

Manager, Technical Customer Support Europe

CPhI China Tradeshow

June 20, 2019

West Helps Simplify the Journey™ in China

Jessie Zhang

Jessie Zhang

Manager, Global Communications, AP

Stoppers and Plungers

May 31, 2019

Stability Studies of Pharmaceutical Packaging Materials in China

Lynn Yao

Lynn Yao

Manager, Scientific Affairs, AP

Load more